Diagnovus has announced the launch of a gene expression assay, ENGAUGE-cancer-DLBCL, designed for use in patients with diffuse large B-cell lymphoma (DLBCL). The assay, which combines patients International Prognostic Index (IPI) score ...
Tags: Diagnovus, B-Cell lymphoma, Medicine
Enzo Biochem has received New York State Department of Health approval for ColonSentry RNA expression assay to assess colorectal cancer risk. The ColonSentry test requires only a small blood sample and can thus be easily incorporated as a ...
Tags: Enzo Biochem, ColonSentry test, ColonSentry RNA expression assay
The molecular cancer diagnostics company, Agendia, has introduced ColoPrint microarray-based 18-gene expression assay. The ColoPrint assay is designed for predicting the risk of distant recurrence for stage II colon cancer patients who ...
Tags: molecular cancer diagnostics, expression assay, cancer diagnostics